Infermedica Raises $10 million Series A for R&D and International Expansion
Dream It
AUGUST 6, 2020
The investment will be used for platform R&D to further enhance patient triage and symptom checking features as well as clinical decision support analysis – including intake collection, differential diagnostics and lab test interpretation – and to expand operations in Germany and the US, where Infermedica currently has one office.
Let's personalize your content